The frequency of prescription of P-glycoprotein-affecting drugs in atrial fibrillation

被引：29

作者：

Jungbauer, L. ^{[1
]}

Dobias, C. ^{[1
]}

Stoellberger, C. ^{[1
]}

Weidinger, F. ^{[1
]}

机构：

[1] Krankenanstalt Rudolfstiftung Wien, Dept Med 2, Vienna, Austria

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2010年 / 8卷 / 09期

关键词：

D O I：

10.1111/j.1538-7836.2010.03943.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2069 / 2070

页数：2

共 5 条

[1]

CHEN J, 2006, PHARMACIST, V25, P732

[2] Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].

Connolly, Stuart J. ;

Ezekowitz, Michael D. ;

Yusuf, Salim ;

Eikelboom, John ;

Oldgren, Jonas ;

Parekh, Amit ;

Pogue, Janice ;

Reilly, Paul A. ;

Themeles, Ellison ;

Varrone, Jeanne ;

Wang, Susan ;

Alings, Marco ;

Xavier, Denis ;

Zhu, Jun ;

Diaz, Rafael ;

Lewis, Basil S. ;

Darius, Harald ;

Diener, Hans-Christoph ;

Joyner, Campbell D. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151

[3] Quality of Care for Atrial Fibrillation Among Patients Hospitalized for Heart Failure [J].

Piccini, Jonathan P. ;

Hernandez, Adrian F. ;

Zhao, Xin ;

Patel, Manesh R. ;

Lewis, William R. ;

Peterson, Eric D. ;

Fonarow, Gregg C. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (14) :1280-1289

[4]

Robertson S, 2007, PRINCIPLES OF CLINICAL PHARMACOLOGY, 2ND EDITION, P229, DOI 10.1016/B978-012369417-1/50055-9

[5] Effects of Kampo Medicines on P-Glycoprotein [J].

Satoh, Toshiyuki ;

Watanabe, Yuka ;

Ikarashi, Nobutomo ;

Ito, Kiyomi ;

Sugiyama, Kiyoshi .

BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2009, 32 (12) :2018-2021

← 1 →